Human Papillomavirus 16 E6 Antibodies in Individuals Without Diagnosed Cancer: A Pooled Analysis

BACKGROUND: The increasing incidence of oropharyngeal cancer in many developed countries has been attributed to human papillomavirus type 16 (HPV16) infections. Recently, HPV16 E6 serology has been identified as a promising early marker for oropharyngeal cancer. Therefore, characterization of HPV16...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Epidemiol Biomarkers Prev
Autores principales: Lang Kuhs, Krystle A., Anantharaman, Devasena, Waterboer, Tim, Johansson, Mattias, Brennan, Paul, Michel, Angelika, Willhauck-Fleckenstein, Martina, Purdue, Mark P., Holcátová, Ivana, Ahrens, Wolfgang, Lagiou, Pagona, Polesel, Jerry, Simonato, Lorenzo, Merletti, Franco, Healy, Claire M., Kjaerheim, Kristina, Conway, David I., Macfarlane, Tatiana V., Thomson, Peter, Castellsagué, Xavier, Znaor, Ariana, Black, Amanda, Huang, Wen-Yi, Krogh, Vittorio, Trichopoulou, Antonia, Bueno-de-Mesquita, H.B(as)., Clavel-Chapelon, Françoise, Weiderpass, Elisabete, Ekström, Johanna, Riboli, Elio, Tjønneland, Anne, Sánchez, María-José, Travis, Ruth C., Hildesheim, Allan, Pawlita, Michael, Kreimer, Aimée R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383678/
https://ncbi.nlm.nih.gov/pubmed/25623733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-14-1217
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares